Similar companies
Income Statement (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Gross Profit | -140,000 | 2.9% |
| Cost of Revenue | 140,000 | 2.9% |
| Operating expense | 7.8M | 0.3% |
| Net Income | -7.5M | 0.5% |
| EBITDA | -7.8M | 1.5% |
Balance Sheet (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Total Assets | 32M | 17.3% |
| Total Liabilities | 8.3M | 8.6% |
| Total Equity | 24M | 19.9% |
| Shares Outstanding | 38M | 8.6% |
Cash Flow (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Cash from operations | -7.1M | 29.9% |
| Cash from investing | -2.7M | 175.6% |
| Cash from financing | 52,000 | 99.5% |
EPS
Financial Highlights for Genelux in Q2 '25
Gross Profit stood at -140,000, marking a -2.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 140,000, a 2.9% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 7.8M, showing a -0.3% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -7.5M, showing a 0.5% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -7.8M, showing a -1.5% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Genelux faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures. A decline in EBITDA signals potential operational challenges or increased costs.
